Although the difference in overall hospital length of stay did not reach statistical significance, patients in the CytoSorb group exhibited longer duration of hospitalization (28.4 ± 18.2 vs. 19.6 ± 6.3 days; p = 0.095).
← all excerpts
CytoSorb<sup>®</sup> Hemadsorption During Microaxial Flow Pump (mAFP) Support in Cardiogenic Shock: A Propensity Score-Matched Cohort Study.
2
0.0950
0.0950
The sentences
Respiratory parameters showed a favorable trend during CytoSorb therapy.